Related Experiment Video
Updated: Jul 30, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.8K
Emerging SARS-CoV-2 variants: Why, how, and what's next?
Yu Chen1, Qianyun Liu1, Li Zhou1
1State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, 430072, China.
Cell Insight
|May 16, 2023
Summary
The Omicron variant of SARS-CoV-2, with over 30 Spike protein mutations, threatens immunity from vaccines or prior infection. Understanding its evolution and immune evasion is crucial for COVID-19 pandemic control.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- The SARS-CoV-2 Omicron variant presents a significant global health challenge.
- Omicron harbors numerous mutations in its Spike protein, impacting vaccine and infection-induced immunity.
- Emerging Omicron sub-lineages (e.g., BA.1, BA.2) and potential recombination events require continuous monitoring.
Purpose of the Study:
- To review the key characteristics of SARS-CoV-2 variants, focusing on Omicron.
- To discuss the evolutionary trajectory and mutation control strategies for SARS-CoV-2.
- To elucidate the immune evasion mechanisms employed by SARS-CoV-2 variants.
Main Methods:
- Literature review of scientific publications on SARS-CoV-2 variants.
- Analysis of mutation data and evolutionary trends.
- Synthesis of information on immune responses and evasion.
Main Results:
- Omicron variant exhibits extensive mutations, significantly reducing neutralization by existing immunity.
- Distinct Omicron lineages (BA.1, BA.2) have emerged, demonstrating rapid transmission.
- Viral recombination between variants like Delta and Omicron is a potential concern requiring further investigation.
Conclusions:
- A comprehensive understanding of SARS-CoV-2 variant characteristics, evolution, and immune evasion is vital.
- This knowledge supports informed decision-making for effective COVID-19 pandemic control strategies.
- Continued surveillance and research are necessary to address the evolving threat of SARS-CoV-2.
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
15.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K
00:36Viral Mutations
32.7K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.7K
00:57Viral Recombination
23.6K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.6K
01:29Viruses with RNA Genomes
60
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
60
01:03Rous Sarcoma Virus (RSV) and Cancer
5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.2K
01:18Steps in Outbreak Investigation
155
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
155